Literature DB >> 22752080

The Green, Amber, Red Delineation of Risk and Need (GARDIAN) management system: a pragmatic approach to optimizing heart health from primary prevention to chronic disease management.

Melinda J Carrington1, Simone Kok, Kiki Jansen, Simon Stewart.   

Abstract

BACKGROUND: A sustained epidemic of cardiovascular disease and related risk factors is a global phenomenon contributing significantly to premature deaths and costly morbidity. Preventative strategies across the full continuum of life, from a population to individual perspective, are not optimally applied. This paper describes a simple and adaptable 'traffic-light' system we have developed to systematically perform individual risk and need delineation in order to 'titrate' the intensity and frequency of healthcare intervention in a cost-effective manner.
METHODS: The GARDIAN (Green Amber Red Delineation of Risk and Need) system is an individual assessment of risk and need that modulates the frequency and intensity of future healthcare intervention. Individual assessment of risk and need for ongoing intervention and support is determined with reference to three domains: (1) clinical stability, (2) gold-standard management, and (3) a broader, holistic assessment of individual circumstance. This can be applied from a primary prevention, secondary prevention, or chronic disease management perspective.
RESULTS: Our experience with applying and validating GARDIAN to titrate healthcare resources according to need has been extensive to date, with >5000 individuals profiled in a host of clinical settings. A series of clinical randomized trials will determine the impact of the GARDIAN system on important indices of healthcare utilization and health status.
CONCLUSIONS: The GARDIAN model to delineating risk and need for varied intensity of management shows strong potential to cost effectively improve health outcomes for both individuals at risk of heart disease and those with established heart disease.

Entities:  

Keywords:  Disease management; prevention; prioritizing care

Mesh:

Year:  2012        PMID: 22752080     DOI: 10.1177/1474515112451702

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  6 in total

Review 1.  Have Traditional Heart Failure Management Programs Reached Their "Use by" Date? Time to Apply More Nuanced Care.

Authors:  Simon Stewart
Journal:  Curr Heart Fail Rep       Date:  2019-06

2.  Applying Heart Failure Management to Improve Health Outcomes: But WHICH One?

Authors:  Yih-Kai Chan; Alice M David; Caitlyn Mainland; Lei Chen; Simon Stewart
Journal:  Card Fail Rev       Date:  2017-11

3.  Impact of Nurse-Led, Multidisciplinary Home-Based Intervention on Event-Free Survival Across the Spectrum of Chronic Heart Disease: Composite Analysis of Health Outcomes in 1226 Patients From 3 Randomized Trials.

Authors:  Simon Stewart; Joshua F Wiley; Jocasta Ball; Yih-Kai Chan; Yasmin Ahamed; David R Thompson; Melinda J Carrington
Journal:  Circulation       Date:  2016-04-15       Impact factor: 29.690

4.  Cost-Effectiveness of a Home Based Intervention for Secondary Prevention of Readmission with Chronic Heart Disease.

Authors:  Joshua Byrnes; Melinda Carrington; Yih-Kai Chan; Christine Pollicino; Natalie Dubrowin; Simon Stewart; Paul A Scuffham
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

5.  Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trial.

Authors:  P A Scuffham; J Ball; J D Horowitz; C Wong; P J Newton; P Macdonald; J McVeigh; A Rischbieth; N Emanuele; M J Carrington; C M Reid; Y K Chan; S Stewart
Journal:  Eur Heart J       Date:  2017-08-07       Impact factor: 29.983

6.  Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.

Authors:  Melinda J Carrington; Paul Zimmet
Journal:  BMC Health Serv Res       Date:  2017-12-06       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.